Ono Pharmaceutical CoMEX:4528N 88 Net Margin % is 0.69% as of Mar. 2026, which is 97% below its 10-year median of 21.35. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 953 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 74.92% on this metric.
The historical rank and industry rank for Ono Pharmaceutical Co's Net Margin % or its related term are showing as below:
MEX:4528N'
s Net Margin % Range Over the Past 10 Years
Min: 10.28 Med: 21.35 Max: 25.46
Current: 13.53
MEX:4528N's Net Margin % is ranked better than 74.92% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs MEX:4528N: 13.53
Ono Pharmaceutical Co (MEX:4528N) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ono Pharmaceutical Co Net Margin % Related Terms
Ono Pharmaceutical Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4528N vs LLY, JNJ, ABBV: Net Margin % Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (MEX:4528N) has a Net Margin % of 0.69% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Ono Pharmaceutical Co and its competitors. This is 97% below median its historical median of 21.35. Over the past decade, Ono Pharmaceutical Co's Net Margin % has ranged from 10.28 to 25.46. According to the industry distribution chart, Ono Pharmaceutical Co ranks #239 out of 953 companies in the Drug Manufacturers industry, placing it in the top 25.1%.
Is Ono Pharmaceutical Co's Net Margin % too high?
Ono Pharmaceutical Co's current Net Margin % of 0.69% is 97% below median its 10-year median of 21.35. Over the past 10 years, this metric has ranged from a low of 10.28 to a high of 25.46. The Drug Manufacturers industry median Net Margin % is 5.69. Ono Pharmaceutical Co's value of 0.69% is 87.9% below this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #239 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Net Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #239 out of 953 companies for Net Margin %. This puts Ono Pharmaceutical Co in the upper half of its industry. The industry median Net Margin % is 5.69. Ono Pharmaceutical Co's value of 0.69% is 87.9% below this benchmark. Historically, Ono Pharmaceutical Co's own Net Margin % has ranged from 10.28 to 25.46 over the past decade. While the company's 10-year median is 21.35 vs. the industry median of 5.69, Ono Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Net Margin % of 0.69% is 87.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Net Margin % is 0.69%, which is 97% below median its own 10-year median of 21.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Net Margin % of 0.69%. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Net Margin % is 0.69%, which is 97% below median its 10-year median of 21.35 and 87.9% below the Drug Manufacturers industry median of 5.69. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Net Margin % is 0.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.
Key valuation signals for MEX:4528N:
Net Margin %: 0.69% (97% below median its 10-year median of 21.35)
GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
Industry Position: 87.9% below the Drug Manufacturers median (#239 of 953)
No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score
Get the complete analysis for MEX:4528N
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4528N has been successfully added to your 
